| Axon ID |
Name |
Description |
From price |
|
1282
|
BAG 956
|
PI3K and PDPK1 inhibitor |
$104.50 |
|
1334
|
PIK 75 hydrochloride
|
PI3K inhibitor (p110-α specific) |
$77.00 |
|
1362
|
PIK 90
|
PI3K inhibitor (p110-α specific) |
$93.50 |
|
1366
|
LY 294002
|
PI3K inhibitor |
$77.00 |
|
1367
|
KU-55933
|
ATM inhibitor |
$121.00 |
|
1377
|
GDC 0941 bismesylate
|
PI3K inhibitor |
$88.00 |
|
1380
|
PI 103 hydrochloride
|
PI3K inhibitor (p110 specific) |
$66.00 |
|
1417
|
TGX 221
|
PI3K inhibitor (p110 β specific) |
$77.00 |
|
1424
|
AS 252424
|
PI3K inhibitor (p110-γ specific) |
$93.50 |
|
1463
|
NU 7441
|
DNA-PK inhibitor |
$44.00 |
|
1495
|
CP 466722
|
ATM inhibitor |
$77.00 |
|
1520
|
NVP-BBD130
|
Dual PI3K and mTOR kinase inhibitor |
$137.50 |
|
1584
|
KU-0060648 trihydrochloride
|
DNA-PK inhibitor |
Inquire |
|
1596
|
GSK 2126458
|
Dual PI3K and mTOR inhibitor |
$55.00 |
|
1706
|
XL PI3K/mTOR inhibitor
|
Dual PI3K and mTOR kinase inhibitor |
$132.00 |
|
1719
|
D 106669
|
Potent and selective PI3K inhibitor |
$93.50 |
|
1782
|
GDC 0980
|
Dual PI3K and mTOR inhibitor |
$88.00 |
|
1797
|
NVP-BKM120
|
Class I PI3K inhibitor |
$99.00 |
|
1807
|
PKI 587
|
Dual PI3K and mTOR inhibitor |
$99.00 |
|
1831
|
A 66
|
PI3K inhibitor (p110-α specific) |
$104.50 |
|
1855
|
PF 04691502
|
PI3K and mTOR tyrosine kinase inhibitor |
$99.00 |
|
1893
|
VE 821
|
Inhibitor of the DNA damage response kinase ATR |
$88.00 |
|
1912
|
GSK 2636771 dihydrochloride
|
PI3K inhibitor (p110 β specific) |
$115.50 |
|
2029
|
NVP-BGT226
|
Orally active dual PI3K/mTOR inhibitor |
$132.00 |
|
2039
|
CZC 24832
|
PI3K inhibitor (p110-γ specific) |
$104.50 |
|
2170
|
CAL 101
|
PI3K inhibitor (p110 δ specific) |
$104.50 |
|
2168
|
IC 87114
|
Potent and highly selective inhibitor of the PI3K p110δ |
$93.50 |
|
1436
|
AS 252424 bispotassium salt
|
PI3K inhibitor (p110-γ specific) |
$104.50 |
|
2345
|
AZ 20
|
Potent, orally active and selective inhibitor of ATR protein kinase |
$115.50 |
|
2452
|
VE 822
|
Selective ATR inhibitor that decreases survival of pancreatic cancer cells |
$121.00 |
|
2604
|
KU-0060648
|
DNA-PK inhibitor |
$148.50 |
|
2610
|
PDK1 inhibitor 2610
|
Dual PI3K/PDPK1 inhibitor; desmethyl analogue of Axon 1282 |
$137.50 |
|
2630
|
eCF309
|
Highly selective and potent inhibitor of mTOR signalling |
$93.50 |
|
2716
|
SAR405
|
PIK3C3/Vps34 inhibitor |
$99.00 |
|
2748
|
Autophinib
|
PIK3C3/Vps34 inhibitor |
$132.00 |
|
2857
|
Acalisib
|
PI3K inhibitor (p110 δ specific) |
$132.00 |
|
2869
|
LX2343
|
BACE 1 inhibitor |
$137.50 |
|
2925
|
Alpelisib
|
PI3K inhibitor (p110-α specific) |
$99.00 |
|
2926
|
AZD6482
|
PI3K inhibitor (p110 β specific) |
$132.00 |
|
2927
|
Taselisib
|
PI3K inhibitor (p110 β sparing) |
$99.00 |
|
2951
|
XL 388
|
Highly potent, selective, ATP-competitive, and orally bioavailable mTOR inhibitor |
$137.50 |
|
3045
|
PI 3065
|
PI3K inhibitor (p110 δ specific) |
$110.00 |
|
3055
|
B591
|
Potent, specific class I PI3K inhibitor |
$137.50 |
|
3584
|
GDC-0084
|
Brain-penetrant dual PI3K and mTOR inhibitor |
$121.00 |
|
3628
|
MHY-1685
|
mTOR inhibitor; Senescence inhibitor |
$55.00 |
|
3794
|
Urolithin A
|
Inhibitor of the PI3K/AKT/mTOR pathway |
$77.00 |
|
3827
|
AMG-511
|
Orally bioavailable, highly potent and selective pan-class I phosphatidylinositol-3 kinase (PI3K) inhibitor |
Inquire |
|
3942
|
BAY-1082439
|
PI3Kα/β-balanced inhibitor |
Inquire |
|
3996
|
AZD2014
|
Orally bioavailable dual mTORC1/mTORC2 inhibitor |
Inquire |
|
3792
|
PITCOIN3
|
Potent, highly selective and cell-permeable PI3KC2α inhibitor |
$231.00 |
|
4075
|
Serabelisib
|
PI3K p110α isoform specific inhibitor |
Inquire |
|
4133
|
IPI-145
|
PI3K p110α/γ isoform specific inhibitor |
Inquire |
|
4149
|
Everolimus
|
Selective and orally active mTOR1 inhibitor |
Inquire |
|
4172
|
PITCOIN4
|
Potent and highly selective PI3KC2α inhibitor |
$242.00 |